Skip to main content
. Author manuscript; available in PMC: 2021 Aug 31.
Published in final edited form as: Clin Cancer Res. 2021 Jan 14;27(7):1941–1948. doi: 10.1158/1078-0432.CCR-20-3037

Table 2.

Area under the receiver operating characteristics curve (AUC), sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV), negative likelihood ratio (LR-) and positive likelihood ratio (LR+) for all lesions were calculated using a cut-off ADC of ≥ 1.5*10−3 mm2/s. In addition, mass and non-mass lesions and lesions with a maximum diameter equal to and below or above 10 mm were considered separately.

AUC
(95%CI)
Sensitivity
(95%CI)
Specificity
(95%CI)
NPV
(95%CI)
PPV
(95%CI)
LR-
(95%CI)
LR+
(95%CI)
Total 400/414 92/282 92/106 400/590
0.784 (0.752-0.814) 96.6% (94.3-98.1) 32.6% (28.2-37.4) 86.8% (83.1-89.8) 67.8% (63.0-72.2) 0.1 (0.06-0.18) 1.43 (1.32-1.56)
Mass lesions 343/352 57/160 57/66 343/446
0.816 (0.779-0.848) 97.4% (95.3-98.7) 35.6% (31.0-40.5) 86.4% (82.6-89.4) 76.9% (72.5-80.8) 0.07 (0.04-0.14) 1.51 (1.35-1.70)
Non-mass lesions 57/62 35/122 35/40 57/144
0.671 (0.598-0.738) 91.9% (88.8-94.3) 28.7% (24.4-33.4) 87.5% (83.8-90.5) 39.6% (34.9-44.5) 0.28 (0.12-0.68) 1.29 (1.13-1.47)
Size ≦10 mm 85/87 41/133 41/43 85/177
0.748 (0.685-0.804) 97.7% (95.6-98.8) 30.8% (26.5-35.6) 95.3% (92.7-97.1) 48.0% (43.1-53.0) 0.07 (0.02-0.30) 1.41 (1.26-1.59)
Size >10 mm 315/327 51/149 51/63 315/413
0.828 (0.791-0.861) 96.3% (93.9-97.8) 34.2% (29.7-39.0) 81.0% (76.8-84.6) 76.3% (71.8-80.2) 0.11 (0.06-0.20) 1.46 (1.30-1.65)

95%CI: 95% confidence interval